[HTML][HTML] Dabrafenib plus trametinib in patients with BRAF V600E-mutant anaplastic thyroid cancer: updated analysis from the phase II ROAR basket study
V Subbiah, RJ Kreitman, ZA Wainberg, JY Cho… - Annals of …, 2022 - Elsevier
Background Combined therapy with dabrafenib plus trametinib was approved in several
countries for treatment of BRAF V600E-mutant anaplastic thyroid cancer (ATC) based on an …
countries for treatment of BRAF V600E-mutant anaplastic thyroid cancer (ATC) based on an …
Novel inhibitor-based therapies for thyroid cancer—An update
M Ratajczak, D Gaweł, M Godlewska - International journal of molecular …, 2021 - mdpi.com
Thyroid cancers (TCs) are the most common tumors of the endocrine system and a constant
rise in the number of TC cases has been observed for the past few decades. TCs are one of …
rise in the number of TC cases has been observed for the past few decades. TCs are one of …
Role of [18F]FDG PET/CT in the management of follicular cell-derived thyroid carcinoma
K Zajkowska, P Cegla, M Dedecjus - Cancer Imaging, 2024 - Springer
Follicular cell-derived thyroid carcinomas constitute the majority of thyroid malignancies.
This heterogeneous group of tumours includes well differentiated, poorly differentiated, and …
This heterogeneous group of tumours includes well differentiated, poorly differentiated, and …
The knockdown of Nrf2 suppressed tumor growth and increased the sensitivity to lenvatinib in anaplastic thyroid cancer
Z Gong, L Xue, M Wei, Z Liu, AC Vlantis… - Oxidative Medicine …, 2021 - Wiley Online Library
Papillary thyroid cancer can dedifferentiate into a much more aggressive form of thyroid
cancer, namely into anaplastic thyroid cancer. Nrf2 is commonly activated in papillary thyroid …
cancer, namely into anaplastic thyroid cancer. Nrf2 is commonly activated in papillary thyroid …
[HTML][HTML] Complete response of metastatic BRAF V600-mutant anaplastic thyroid cancer following adjuvant dabrafenib and trametinib treatment: A case report
SJ Lee, SY Song, MK Kim, HG Na, CH Bae… - World Journal of …, 2023 - ncbi.nlm.nih.gov
BACKGROUND Anaplastic thyroid cancer (ATC) is a rare but aggressive type of thyroid
carcinoma. BRAF V600E-mutation, which is found in 10%-50% of ATCs, is associated with …
carcinoma. BRAF V600E-mutation, which is found in 10%-50% of ATCs, is associated with …
Trends in Mortality for Anaplastic Thyroid Cancer: Have We Made Progress?
BN Titanji, M Earley, E Kebebew - Journal of Surgical Research, 2024 - Elsevier
Introduction Anaplastic thyroid cancer (ATC) has one of the highest mortality rates of all
human malignancies, accounting for two-thirds of all thyroid cancer deaths. Despite …
human malignancies, accounting for two-thirds of all thyroid cancer deaths. Despite …
Efficacy and Safety of Fuzheng Yiqi Kang‐Ai Decoction Combined with External Irradiation in the Treatment of Undifferentiated Thyroid Carcinoma and Its Influence on …
L Bian, J Zhang, P Wang - Journal of Oncology, 2022 - Wiley Online Library
Objective. To explore the efficacy and safety of Fuzheng Yiqi Kang‐ai (FZYQKA for short)
decoction with external irradiation in the treatment of undifferentiated thyroid carcinoma …
decoction with external irradiation in the treatment of undifferentiated thyroid carcinoma …
[HTML][HTML] Thyroid Cancer: From Genes to Treatment–Recent Developments
I Kostoglou-Athanassiou - Thyroid Cancer-The Road From Genes …, 2023 - intechopen.com
Thyroid cancer carries a good prognosis in most cases and is treated by thyroidectomy,
radioiodine administration thereafter, thyroxine treatment. Although, most cases of thyroid …
radioiodine administration thereafter, thyroxine treatment. Although, most cases of thyroid …